Case Study: The Journey to a Fully Digital Cell Therapy Manufacturing Suite|
In this presentation, Stephen Hill (COO) from Lyell and Judith Koliwer (Principal Consultant Cell and Gene Therapy) from Körber Pharma Software will provide insights into their partnership, lessons learned as well as a benefit analysis of a digital manufacturing facility implementation. The cell and gene therapy industry is currently in a pivotal phase, with significant increases in the number of companies and clinical trials, as observed in the last years and expected to come in the near future. The availability and analysis of digital data as well as increased efficiency during process execution and review processes are considered key drivers to support the industry during this phase. Simultaneously, very little standardization of processes and procedures is available for the respective companies to build upon for their digital journey. This presentation aims to provide a model approach for a patient’s journey through an integrated digital ecosystem from collection to treatment as well as first-hand experience and learnings from one of the first fully digital cell and gene therapy companies.